Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with one of the following lung conditions: idiopathic pulmonary fibrosis (IPF), familial pulmonary fibrosis (FPF), another type of scarring lung disease (such as fibrotic hypersensitivity pneumonitis, a specific type called iNSIP, a lung disease linked to a connective tissue condition, or an unclassified scarring lung disease), or early lung abnormalities spotted on a scan (called interstitial lung abnormalities).
• Your lungs are working well enough to meet certain breathing test results during the screening period — specifically, your lung capacity (FVC) is at least 45% of what is expected, your airflow ratio (FEV1/FVC) is 0.7 or above, and your lungs' ability to transfer oxygen into the blood (DLco) is at least 40% of what is expected (confirm with trial site if unsure about your results).
• You are able to give written consent to take part in the study, as approved by an ethics committee.
• You are able to have a CT scan and complete breathing (lung function) tests.
• You are between 18 and 80 years old.
• You can understand Dutch or English.

Who may not be able to join:

• You have been diagnosed with a combination of pulmonary fibrosis and emphysema (CPFE).
• You have chronic obstructive lung disease (COPD) with an airflow ratio (FEV1/FVC) below 70%.
• You have severe asthma that is not well controlled.
• You currently have an active cancer, unless it is a low-risk skin cancer (squamous cell carcinoma), low-risk breast cancer, or low-risk prostate cancer.
• You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.